NO911021L - Fremgangsmaate og preparat for iontoforese. - Google Patents

Fremgangsmaate og preparat for iontoforese.

Info

Publication number
NO911021L
NO911021L NO91911021A NO911021A NO911021L NO 911021 L NO911021 L NO 911021L NO 91911021 A NO91911021 A NO 91911021A NO 911021 A NO911021 A NO 911021A NO 911021 L NO911021 L NO 911021L
Authority
NO
Norway
Prior art keywords
compositions
delivery
iontophorese
preparation
vasodilator
Prior art date
Application number
NO91911021A
Other languages
English (en)
Other versions
NO911021D0 (no
Inventor
Jr Burton H Sage
James E Riviere
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/653,202 external-priority patent/US5302172A/en
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of NO911021D0 publication Critical patent/NO911021D0/no
Publication of NO911021L publication Critical patent/NO911021L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Stringed Musical Instruments (AREA)
  • Control Of El Displays (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Fremgangsmåter og preparater for forbedret iontoforetisk avlevering av aktive bestanddeler.Preparatene er farmasøytisk aksepterbare preparater for iontoforetisk avlevering omfattende en avleverings-forbedrende mengde av en vasodilator og aktiv bestanddel .Fremgangsmåtene omfatter tilsetning av en avleverings-forbedrende mengde av en vasodilator til en aktiv bestanddel og avlevering ved iontoforese.
NO91911021A 1990-03-15 1991-03-14 Fremgangsmaate og preparat for iontoforese. NO911021L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49406290A 1990-03-15 1990-03-15
US07/653,202 US5302172A (en) 1990-03-15 1991-02-08 Method and composition for iontophoresis

Publications (2)

Publication Number Publication Date
NO911021D0 NO911021D0 (no) 1991-03-14
NO911021L true NO911021L (no) 1991-09-16

Family

ID=27051282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911021A NO911021L (no) 1990-03-15 1991-03-14 Fremgangsmaate og preparat for iontoforese.

Country Status (11)

Country Link
EP (1) EP0449463B1 (no)
JP (1) JPH074432B2 (no)
AT (1) ATE114466T1 (no)
AU (1) AU634867B2 (no)
DE (1) DE69105322T2 (no)
DK (1) DK0449463T3 (no)
ES (1) ES2075934T3 (no)
FI (1) FI911268A (no)
IE (1) IE64873B1 (no)
NO (1) NO911021L (no)
NZ (1) NZ237333A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2863757B2 (ja) * 1992-02-17 1999-03-03 ドラッグ デリバリー システムズ インコーポレイテッド 電気的経皮薬剤アプリケータ
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
BR9709780A (pt) * 1996-06-12 1999-08-10 Alza Corp Eletrotransporte otimizado de agentes terapêuticos tendo contra-íons aniônicos polibásicos
US6004577A (en) * 1997-08-12 1999-12-21 Murdock; Thomas O. Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
US20060013769A1 (en) * 2004-07-16 2006-01-19 Stephen Carter Transdermal drug delivery formulations and method of determining optimal amounts of vasodilators therein
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein
EP1968540A2 (en) * 2005-08-05 2008-09-17 Universite De Geneve Topical drug delivery by iontophoresis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659714A (en) * 1984-03-27 1987-04-21 Dentsply, Ltd. Anesthetic methods for mammals

Also Published As

Publication number Publication date
DE69105322D1 (de) 1995-01-12
DK0449463T3 (da) 1995-01-23
DE69105322T2 (de) 1995-05-18
AU7278591A (en) 1991-09-19
JPH0679004A (ja) 1994-03-22
ES2075934T3 (es) 1995-10-16
EP0449463A2 (en) 1991-10-02
IE910715A1 (en) 1991-09-25
JPH074432B2 (ja) 1995-01-25
EP0449463B1 (en) 1994-11-30
AU634867B2 (en) 1993-03-04
ATE114466T1 (de) 1994-12-15
NO911021D0 (no) 1991-03-14
NZ237333A (en) 1993-08-26
FI911268A (fi) 1991-09-16
EP0449463A3 (en) 1991-12-27
IE64873B1 (en) 1995-09-20
FI911268A0 (fi) 1991-03-14

Similar Documents

Publication Publication Date Title
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
DK0395329T3 (da) Sammensætning i form af et skum indeholdende 5-aminosalicylsyre til intrarektal administration
SG77626A1 (en) Compositions and methods for topical administration of pharmaceutically active agents
GR1003711B (el) Μεθοδος δια την παρασκευη φαρμακευτικων συνθεσεων δια συστηματικην διαδερμικην χορηγησιν.
ITMI951278A0 (it) Formulazioni di analoghi dell'insulina
FI933393A (fi) Agglomererade hydrofila komplex med flerfasiga frigoeringsegenskaper
ES2123287T3 (es) Derivados 3-benzoil benzofuranicos como antagonistas de la hormona tiroidea.
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
EE200200565A (et) Vaskulaarse kahjustava toimega kombinatsioonravi
IL131811A0 (en) Antitussive compositions
PH21102A (en) Improvements in or relating to benzothiophene derivatives as antiastmatic agents
NO911021D0 (no) Fremgangsmaate og preparat for iontoforese.
SE8303003L (sv) Medel for att oka antitumorverkan hos antitumormedel
NO911022D0 (no) Fremgangsmaate og preparat for oeket hudkonsentrasjon av aktive bestanddeler ved iontoforese.
EP0295695A3 (en) New pyrazoline derivatives and agents for treating cerebnew pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredrovascular diseases containing the same as active ingredient ient
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
NZ237400A (en) Amino and quaternary ammonium derivatives of ascorbic acid; use in combating reperfusion damage
IT1172264B (it) Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo
IT1163571B (it) Derivati dell'isoindolina e composizioni terapeutiche che li comprendono come principio attivo
ZA885142B (en) Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.